China Top 10 Freeze Dried Vaccine Potential Enterprises

July 19, 2024

The freeze-dried vaccine industry is rapidly expanding due to its longer shelf life, easier transportation, and reduced need for refrigeration. Companies are investing in research and development to create more freeze-dried vaccines for various diseases, making immunization more accessible worldwide.

Shanghai Zerun Biotechnology Co. Ltd.
Changchun Zhuoyi Biological Co., Ltd
Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
Walvax Biotechnology Co. Ltd.

Shanghai Zerun Biotechnology Co. Ltd.

Establishment time : 2017

website : www.zerunbio.com

Main Product : Biotechnology products and services

Company Profile

Shanghai Zerun Biotechnology Co. Ltd. is a biotechnology company founded in 2017. We specialize in developing innovative biotechnology products and services for various industries. Our main markets are in China and the Asia-Pacific region. Despite facing strong competition from established biotechnology companies, we strive to differentiate ourselves through our cutting-edge research and commitment to quality. Visit our website at www.zerunbio.com for more information.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.

Establishment time : Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. was founded in 1991.

website :

Main Product : It is a medium-sized company with a strong presence in both domestic and international markets.

Company Profile

The company's website is www.bwbg.com.cn for more information.

Walvax Biotechnology Co. Ltd.

Establishment time : Walvax Biotechnology Co. Ltd. was founded in 1993.

website :

Main Product : With a medium-sized workforce, Walvax has established a strong presence in the Chinese and international markets.

Company Profile

Walvax continues to expand its product line and market reach to better serve its customers.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326